DongKook Life Science Co., Ltd. Q3 revenue KRW 26.5 billion, operating loss of KRW 1.6 billion after a swing to loss
AI summary · Not investment advice
In Q3 the company sold KRW 26.5 billion of goods and lost KRW 1.6 billion from its main business, after a profit in the same period last year.
Operating profit · 3 months
KRW -1.6 billion
Key facts
- Revenue (3 months)
- KRW 26.5 billion
- Net income (3 months)
- KRW -506.1 million
- Period
- Q3 (cumulative 2026.01.01 ~ 2026.09.30)
- Revenue (prior-year 3 months)
- KRW 29.4 billion
- Revenue (year to date)
- KRW 83.9 billion
- Operating profit (prior-year 3 months)
- KRW 4.3 billion
- Operating profit (year to date)
- KRW 1.9 billion
- Net income (prior-year 3 months)
- KRW 2.4 billion
- Net income (year to date)
- KRW 911.8 million
Commentary
AI commentary · Not investment advice
What happened
Dongkook Life Science reported its separate-basis results for the third quarter of 2026 in its quarterly report. Sales for the 3 months were KRW 26.5 billion. That is 9.9% lower than the same 3 months a year earlier (KRW 29.4 billion). It is 9.3% higher than the previous quarter.
In the company's terms
Operating profit (profit from the core business) for the 3 months was a loss of KRW 1.6 billion, a swing from a profit of KRW 4.3 billion a year earlier. Net income (final profit after taxes and all other items) for the 3 months was a loss of KRW 0.5 billion. A year earlier it was a profit of KRW 2.4 billion.
What changes for shareholders
For the year to date (January 1 to September 30), sales were KRW 83.9 billion. Operating profit was KRW 1.9 billion. Net income was KRW 0.9 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
D